Study of AVZO-021 in Patients With Advanced Solid Tumors
מצבים רפואיים
Advanced Solid Tumor · HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer · CCNE1 Amplification · Epithelial Ovarian Cancer · Primary Peritoneal Cancer · Fallopian Tube Cancer · Endometrial Cancer · TNBC - Triple-Negative Breast Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Yale Cancer Center)Florida Cancer Specialists, Sarasota, Florida, United States
Contact: Study coordinator (Florida Cancer Specialists)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Moffitt Cancer Center)Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York, United States
Contact: Study coordinator (Perlmutter Cancer Center at NYU Langone Hospital - Long Island)NYU Langone Medical Center (Tisch Hospital), New York, New York, United States
Contact: Study coordinator (NYU Langone Medical Center (Tisch Hospital)University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Study coordinator (University Hospitals Cleveland Medical Center)Oklahoma University, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Oklahoma University)Providence Cancer Institute, Portland, Oregon, United States
Contact: Study coordinator (Providence Cancer Institute)Sidney Kimmel Cancer Center (SKCC) at Jefferson Health, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Sidney Kimmel Cancer Center (SKCC)Texas Oncology - DFW, Dallas, Texas, United States
Contact: Study coordinator (Texas Oncology - DFW)NEXT Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (NEXT Virginia)Macquarie University Hospital, Macquarie University, New South Wales, Australia
Contact: Study coordinator (Macquarie University Hospital)Cancer Care Wollongong, Wollongong, New South Wales, Australia
Contact: Study coordinator (Cancer Care Wollongong)